Marriage Counselors in Shelbyville, TN Accepting Medicare

2 Marriage Counselors found. Showing 1 - 2

Ashley Townsend Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1612 N Main St Ste D, Shelbyville, TN 37160 Phone: 931-909-0050

Maria Voigts Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 604 S Wall St, Shelbyville, TN 37160 Phone: 931-684-0522

News Archive

Genetic discovery may lead to new blood test for people at high risk for cancer

Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Scientists discovered a new way breast cancer cells dodge the immune system and promote tumor growth, providing a fresh treatment target in the fight against the disease. While comparable mechanisms to avoid the immune system have been identified in mice with breast and other cancers, the study tested human breast tumor cells, putting researchers closer to understanding how the disease progresses in real patients.

Study finds no overall improvement in heart transplant waitlist after policy change

In March 2016, the Organ Procurement and Transplantation Network revised its criteria for prioritizing children awaiting heart transplantation in the U.S. with the intention of reducing the number of deaths on the waitlist, but a new study suggests unintended consequences.

Postmenopausal women who are "apple" shaped have greater risk of heart problems

Postmenopausal women who are "apple" shaped rather than "pear" shaped are at greater risk of heart and blood vessel problems, even if they have a normal, healthy body mass index according to new research.

Plexxikon commences patient dosage in PLX4032 trials for metastatic melanoma

Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight percent of all solid tumors.

Read more Medical News

› Verified 8 days ago